Applied Spectral Imaging (ASI) Announces the Launch of the GenASIs Automated Imaging Platforms for Genetic and Pathology Analysis
CARLSBAD, Calif.--(BUSINESS WIRE)--Dec. 19, 2011 - Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced today general availability of the GenASIs automated imaging platforms for genetic and pathology analysis.
The GenASIs advanced cytogenetic and pathology platforms are the foundation of ASI’s new offering. With its superior imaging and analysis capabilities, ASI provides state of the art diagnostic aids, offering cytogeneticists and pathologists accurate genetic and pathology analysis.
The GenASIs advanced cytogenetic and pathology platforms are the foundation of ASI’s new offering. With its superior imaging and analysis capabilities, ASI provides state of the art diagnostic aids, offering cytogeneticists and pathologists accurate genetic and pathology analysis.